Trial ID: | L0893 |
Source ID: | ChiCTR-TRC-14004660
|
Associated Drug: |
Metformin
|
Title: |
Comparison of efficacy of liraglutide, metformin and gliclazide MR on hepatic lipid content in patients with type 2 diabetes (T2DM) and non-alcoholic fatty liver (NAFLD)
|
Acronym: |
--
|
Status: |
Not Recruiting
|
Study Results: |
No Results Available
|
Results: |
--
|
Conditions: |
Type 2 Diabetes, Non-alcoholic fatty liver
|
Interventions: |
A:Liraglutide;B:Metformin;C:Metformin;
|
Outcome Measures: |
Liver fat content(Quantitative ultrasound);HbA1;Liver function;blood inflammatory markers;Lipid levels;Body mass index;WH;
|
Sponsor/Collaborators: |
Drum Tower Hospital Affiliated to Nanjing University Medical School
|
Gender: |
Male
|
Age: |
1870
|
Phases: |
Post-market
|
Enrollment: |
A:30;B:30;C:3;
|
Study Type: |
Interventional study
|
Study Designs: |
Randomized parallel controlled trial
|
Start Date: |
21/09/2014
|
Completion Date: |
--
|
Results First Posted: |
--
|
Last Update Posted: |
18 April 2017
|
Locations: |
china
|
URL: |
http://www.chictr.org.cn/showproj.aspx?proj=4913
|